Biomedical Science and Research Journals | Indonesian Single Rod Implant: A New Breakthrough
Implant as a contraceptive device was begun for the clinical trial
in 1968 in Santiago, Chile. The tube contained polydimethylsiloxane
(silastic or silicon) which was filled by chlormadinone acetate as
synthetic gestagen or progestin. However, the trial was stopped due
to toxicity in animal experiments. Several years later, six rods
implant containing megestrol acetate was run for clinical trial in
Chile, India, and Brazil; unfortunately, it stopped because of ectopic
pregnancy as consequence of failure. In 1980, there was a trial
to compare six- (Norplant®) and two-rod-implant (Norplant-2®)
containing levonogestrel (LNG) and continued by the development
of Jadena® marketed in Indonesia which was officially accepted
by FDA in 1996. Indonesian implant developed single rod
marketed as Indoplant® containing 150 mg LNG and Monoplant®
consisting of 160 mg LNG. Monoplant® was estimated for 3 years
of effectiveness as contraceptive. Therefore, this article would
like to present a novel idea in the advancement of Monoplant® for
consideration for publication in American Journal of Biomedical
Science & Research.
For More information: biomedical open access Journals: https://biomedgrid.com/index.p
Bimedical Science and research
Comments
Post a Comment